BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37531615)

  • 1. Approach to the Patient With Parathyroid Carcinoma.
    Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
    J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on parathyroid carcinoma.
    Cetani F; Pardi E; Marcocci C
    J Endocrinol Invest; 2016 Jun; 39(6):595-606. PubMed ID: 27001435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.
    Cetani F; Pardi E; Marcocci C
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):683-709. PubMed ID: 34774241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid cancer.
    Sharretts JM; Kebebew E; Simonds WF
    Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid carcinoma.
    Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A family case report of parathyroid carcinoma associated with
    Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
    Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
    Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid Carcinoma.
    Cetani F; Pardi E; Marcocci C
    Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
    Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
    Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid cancer: An update.
    Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
    Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
    Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
    World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid carcinoma: molecular therapeutic targets.
    Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
    Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
    Cardoso L; Stevenson M; Thakker RV
    Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid carcinoma: a clinical and genetic perspective.
    Cetani F; Pardi E; Marcocci C
    Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
    Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
    Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent or persistent hyperparathyroidism.
    Wells SA; Debenedetti MK; Doherty GM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N158-62. PubMed ID: 12412795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the treatment of parathyroid carcinoma: a case report.
    Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
    Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of parathyroid tumours.
    Thakker RV
    J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
    Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.